These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7625810)

  • 1. Comparative antibacterial activity of L-695,256, a carbapenem active against methicillin-resistant staphylococci.
    Rylander M; Rollof J; Jacobsson K; Norrby SR
    Antimicrob Agents Chemother; 1995 May; 39(5):1178-81. PubMed ID: 7625810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of sanfetrinem against isolates of Streptococcus pneumoniae and Staphylococcus aureus.
    Johnson AP; Warner M; Speller DC
    J Antimicrob Chemother; 1998 Nov; 42(5):643-6. PubMed ID: 9848449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of BO-3482, a novel dithiocarbamate carbapenem with activity against methicillin-resistant staphylococci.
    Adachi Y; Nakamura K; Kato Y; Hazumi N; Hashizume T; Nakagawa S
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2282-5. PubMed ID: 9333063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
    Pillar CM; Aranza MK; Shah D; Sahm DF
    J Antimicrob Chemother; 2008 Mar; 61(3):595-602. PubMed ID: 18218646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus.
    Sumita Y; Nouda H; Kanazawa K; Fukasawa M
    Antimicrob Agents Chemother; 1995 Apr; 39(4):910-6. PubMed ID: 7785994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
    Nagano R; Shibata K; Adachi Y; Imamura H; Hashizume T; Morishima H
    Antimicrob Agents Chemother; 2000 Mar; 44(3):489-95. PubMed ID: 10681308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus.
    Hanaki H; Akagi H; Masaru Y; Otani T; Hyodo A; Hiramatsu K
    Antimicrob Agents Chemother; 1995 May; 39(5):1120-6. PubMed ID: 7625799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009.
    Jean SS; Hsueh PR; Lee WS; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Lam C; Chen RJ
    Int J Antimicrob Agents; 2013 May; 41(5):457-62. PubMed ID: 23507415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activities of L-695,256, a novel carbapenem, against gram-positive bacteria.
    Malanoski G; Collins L; Eliopoulos CT; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 1995 Apr; 39(4):990-5. PubMed ID: 7786011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci.
    Kurazono M; Ida T; Yamada K; Hirai Y; Maruyama T; Shitara E; Yonezawa M
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2831-7. PubMed ID: 15273088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.
    Asahi Y; Miyazaki S; Yamaguchi K
    Antimicrob Agents Chemother; 1995 May; 39(5):1030-7. PubMed ID: 7625784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity of FCE 22101 against relatively resistant blood culture isolates.
    Qadri SM; Ueno Y; Ellis ME
    Chemotherapy; 1991; 37(1):15-22. PubMed ID: 2013238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.
    Chanal C; Sirot D; Chanal M; Cluzel M; Sirot J; Cluzel R
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():133-41. PubMed ID: 2808205
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Castanheira M; Davis AP; Mendes RE; Serio AW; Krause KM; Flamm RK
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial properties of imipenem with special reference to the activity against methicillin-resistant staphylococci, cefotaxime-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
    Vurma-Rapp U; Kayser FH; Barberis-Maino L
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():27-33. PubMed ID: 3102452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anti-MRSA and anti-VRE carbapenems; synthesis and structure-activity relationships of 1beta-methyl-2-(thiazol-2-ylthio)carbapenems.
    Sunagawa M; Itoh M; Kubota K; Sasaki A; Ueda Y; Angehrn P; Bourson A; Goetschi E; Hebeisen P; Then RL
    J Antibiot (Tokyo); 2002 Aug; 55(8):722-57. PubMed ID: 12374386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of imipenem on aerobic bacteria.
    Acar JF; Goldstein FW; Kitzis MD; Gutmann L
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():37-45. PubMed ID: 6421793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
    Patel R; Rouse MS; Piper KE; Steckelberg JM
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):119-22. PubMed ID: 10354862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.